Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells

Planta Medica

Volumn 74, Issue 11, 2008, Pages 1357-1362

  Su, Chin Cheng ^a   Chen, Guang Wei ^b   Kang, Jung Cheng ^a   Chan, Ming Huan ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Caspase; Colo 205; Fas; Tanshinone IIA

Indexed keywords

CASPASE; CYTOCHROME C; FAS ANTIGEN; P21 ACTIVATED KINASE; PROTEIN P53; QUINONE DERIVATIVE; TANSHINONE; TANSHINONE IIA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANIMALS; BALB 3T3 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; MICE; PHENANTHRENES;

CITRUS MACROPHYLLA;

EID: 52949101728     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081299     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30
2. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 2005; 4: 274-86
3. Boon H, Wong J. Botanical medicine and cancer: a review of the safety and efficacy. Expert Opin Pharmacother 2004; 5: 2485-501
4. Fish JM, Wetchons DR, Kim YS, Lee SH, Ho WK, Antzelevitch C. Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 2006; 113: 1393-400
5. Chang PN, Mao JC, Huang SH, Ning L, Wang ZJ, On T et al. Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. J Pharmacol Sci 2006; 101; 245-9
6. Che AJ, Zhang JY, Li CH, Chen XF, Hu ZD, Chen XG. Separation and determination of active components in Radix Salviae miltiorrhizae and its medicinal preparations by nonaqueous capillary electrophoresis. J Sep Sci 2004; 27: 569-75
7. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45: 1345-59
8. Lin R, Wang WR, Liu JT, Yang GD, Han CJ. Protective effect of tanshinone HA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. J Ethnopharmacol 2006; 108: 217-22
9. Wang AM, Sha SH, Lesniak W, Schacht J. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 2003; 47: 1836-41
10. Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 2006; 542: 1-7
11. Li W, Li J, Ashok M, Wu R, Chen D, Yang L et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 2007; 78: 3856-64
12. Ryu SY, Lee CO, Choi SU. In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza. Planta Med 1997; 63: 339-42
13. Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 2007; 27: 133-48
14. Sung HJ, Choi SM, Yoon Y, An KS. Tanshinone IIA, an ingredient of Salvia miltiorrhiza Bunge, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med 1999; 31: 174-8
15. Liu JJ, Lin DJ, Liu PQ, Huang M, Li XD, Huang RW. Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. J Biomed Sci 2006; 13: 813-23
16. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J et al. Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 2005; 116: 799-807
17. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J. Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 2004; 10: 2024-8
18. Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 2005; 25: 971-9
19. Chen HC, Hsieh WT, Chang WC, Chung JG. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 2004; 42: 1251-7
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54
21. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639-49
22. Yuan S, Wang Y, Chen X, Song Y, Yang Y. A study on apoptosis of nasopharyngeal carcinoma cell line induced by Tanshinone II Aand its molecular mechanism. Hua Xi Yi Ke Da Xue Xue Bao 2002; 33: 84-6
23. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005; 11: 3155-62
24. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577-90
25. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16
26. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432: 307-15
27. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two CD95 (APO-1/Fas) signaling pathways. Embo J 1998; 17: 1675-87
28. Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M et al. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 1995; 11: 1939-46
29. Petak I, Tillman DM, Houghton JA. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines. Clin Cancer Res 2000; 6: 4432-41